Officers

President
PresidentDavid Corey, Ph.D.
UT Southwestern
Medical Center at Dallas
President Elect
President ElectRichard Geary, Ph.D.
Ionis Pharmaceuticals
Secretary
SecretaryAnnabelle Biscans, Ph.D.
AstraZeneca
Treasurer
TreasurerMartin Maier, Ph.D.
Alnylam Pharmaceuticals
Immediate Past President
Immediate Past PresidentAnnemieke Aartsma-Rus, Ph.D.
Leiden University
Medical Center

Directors

Shalini Andersson, Ph.D.
Shalini Andersson, Ph.D.
AstraZeneca
Isabel Aznarez, Ph.D.
Isabel Aznarez, Ph.D.
Stoke Therapeutics
Masad J. Damha, Ph.D.
Masad J. Damha, Ph.D.
McGill University
Bruno Godinho, Ph.D.
Bruno Godinho, Ph.D.
Atalanta Therapeutics
Maja Janas De Angelis, Ph.D., DABT
Maja Janas De Angelis, Ph.D., DABT
Alnylam Pharmaceuticals
Rebecca Miles, Ph.D.
Rebecca Miles, Ph.D.
Eli Lilly and Co.
Laura Sepp-Lorenzino, Ph.D.
Laura Sepp-Lorenzino, Ph.D.
CSO, Intellia Therapeutics
Bruce Sullenger, Ph.D.
Bruce Sullenger, Ph.D.
Duke University
Marie Wikström Lindholm, Ph.D.
Marie Wikström Lindholm, Ph.D.
Silence Therapeutics
Takanori Yokota, M.D., Ph.D.
Takanori Yokota, M.D., Ph.D.
Tokyo Medical and Dental University
Timothy Yu, M.D., Ph.D.
Timothy Yu, M.D., Ph.D.
Harvard/Boston Children’s Hospital

Trainee Representatives

Current PhD students or postdocs, elected to represent their fellow trainees on the OTS Board

Leonora Abdullahu, Ph.D.
Leonora Abdullahu, Ph.D.
Eli Lilly & Co
Hassan Fakih, Ph.D.
Hassan Fakih, Ph.D.Post-Doctoral Associate

RNA Therapeutics Institute
UMASS Chan Medical School

Chantal Ferguson, M.D., Ph.D. Candidate
Chantal Ferguson, M.D., Ph.D. Candidate
RNA Therapeutics Institute
UMASS Chan Medical School
Aurélie Lacroix, Ph.D.
Aurélie Lacroix, Ph.D.
Sixfold Bioscience

Honorary Members

Appointed for life in honor of their major, sustained contributions to the society and the field.

Fritz Eckstein, Ph.D.
Fritz Eckstein, Ph.D.
Max-Planck-Institute for Multidisciplinary Sciences
Mike Gait, Ph.D.
Mike Gait, Ph.D.
Medical Research Council
John Rossi, Ph.D.
John Rossi, Ph.D.
City of Hope